Public Health Genomics

Policy Statement

Capacity-Building in Human Genetics for Developing Countries: Initiatives and Perspectives in Sub-Saharan Africa

Wonkam A.a, b · Muna W.a · Ramesar R.b · Rotimi C.N.c · Newport M.J.d

Author affiliations

aFaculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon; bMRC/UCT Human Genetics Research Unit, Division of Human Genetics, Institute for Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; cCenter for Research on Genomics and Global Health, National Institutes of Health, Bethesda, Md., USA; dBrighton and Sussex Medical School, Falmer, UK

Related Articles for ""

Public Health Genomics 2010;13:492–494

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Policy Statement

Received: June 23, 2009
Accepted: October 16, 2009
Published online: March 23, 2010
Issue release date: December 2010

Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0

ISSN: 1662-4246 (Print)
eISSN: 1662-8063 (Online)

For additional information: https://www.karger.com/PHG

Abstract

Background: Stakeholders who are committed to bridge the gap in genetics services need to be aware of current initiatives in sub-Saharan Africa. Methods: We reviewed selected experiences from African geneticists that led to specific recommendations. Results: The initiation of prenatal diagnosis of sickle cell anaemia founded the first medical genetic service in Cameroon. There remains a need for international collaborative effort to overcome the lack of human, technical and financial resources around the practice of medical genetics in Africa. The African Society of Human Genetics, Wellcome Trust and NIH have recently proposed a model on how to fully engage Africa in genomics. It includes a ‘Health and disease’ phase I: use of the case-control design to study genetic and epidemiological determinants of 7 important diseases in Africa, and a ‘Genetic variation’ phase II: comprehensive documentation of genetic variations in 100 carefully selected ethnic groups across Africa. The strategy would require the development of: (1) clinical phenotyping centres, (2) molecular phenotyping centres, (3) genotyping and sequencing capability, (4) data centres, and (5) a bio-repository in Africa. Conclusions: Governments and international health agencies need to recognise that genetics is important to the global medical community. The initiatives of African geneticists need advocacy and encouragement from the international community.

© 2010 S. Karger AG, Basel




Related Articles:


References

  1. World Health Organization: Control of genetic diseases. Report 2005. Available at http://apps.who.int/gb/ebwha/pdf_files/EB116/B116_3-en.pdf.
  2. Weatherall DJ: Hemoglobinopathies worldwide: present and future. Curr Mol Med 2008;8:592–599.
  3. Alwan A, Modell B: Recommendations for introducing genetics services in developing countries. Nat Rev Genet 2003;4:61–68.
  4. Collins FS: Shattuck lecture – medical and societal consequences of the Human Genome Project. N Engl J Med 1999;341:28–37.
  5. Wonkam A, Njamnshi AK, Angwafo III FF: Knowledge and attitudes concerning medical genetics amongst physicians and medical students in Cameroon (sub-Saharan Africa). Genet Med 2006;8:331–338.
  6. Wonkam A, Hurst SA: Acceptance of abortion by doctors and medical students in Cameroon. Lancet 2007;369:1999.
  7. Rotimi CN: Inauguration of the African Society of Human Genetics. Nat Genet 2004;36:544.
  8. Ana JN: Africa’s medical brain drain: brain gain and brain circulation result when drain is reserved. BMJ 2005;331:780.
  9. Newport MJ, Rotimi CN: Reducing the global genomic inequity gap: development of an African Genome Project. Public Health Genomics 2009;12:251–252.
    External Resources
  10. Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A, Hirbo JB, Awomoyi AA, Bodo JM, Doumbo O, Ibrahim M, Juma AT, Kotze MJ, Lema G, Moore JH, Mortensen H, Nyambo TB, Omar SA, Powell K, Pretorius GS, Smith MW, Thera MA, Wambebe C, Weber JL, Williams SM: The genetic structure and history of Africans and African Americans. Science 2009;324:1035–1044.
  11. Hardy BJ, Séguin B, Ramesar R, Singer PA, Daar AS: South Africa: from species cradle to genomic applications. Nat Rev Genet 2008;9(suppl 1):19–23.
    External Resources
  12. Anonymous: Developing genetics for developing countries (editorial). Nat Genet 2007;39:1287.

Article / Publication Details

First-Page Preview
Abstract of Policy Statement

Received: June 23, 2009
Accepted: October 16, 2009
Published online: March 23, 2010
Issue release date: December 2010

Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0

ISSN: 1662-4246 (Print)
eISSN: 1662-8063 (Online)

For additional information: https://www.karger.com/PHG


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP